US$ 27.38
mechanism of action for glp 1 receptor agonists Glucagon-like peptide agonists: cardiovascular benefits and mechanisms Current Insights, Advantages and Challenges
Description
Microbiota depletion in HFD-fed mice elevates plasma GLP-1 levels and attenuates hypothalamic inflammation, actions that require the astrocyte GLP-1R (49)

The starting dosage is 0.8 milligrams (mg), increased to 2.5 mg after at least 30 days, and then to 5.5 mg after another 30 days

Post-approval Exclusivities Drug manufacturers listed 22 patents after FDA approval of the 10 products in the cohort (median 1.5 [IQR: 02.8]), including 11 patents on devices (50%)

Poll: roughly 12% of US adults have used a GLP-1 drug, even if unaffordable

PMID: 11014225

Bezin J., Gouverneur A., Pnichon M., et al., GLP1 Receptor Agonists and the Risk of Thyroid Cancer, Diabetes Care 46 (2022): 384390
